These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30761437)

  • 1. Surface Dissolution UV Imaging for Investigation of Dissolution of Poorly Soluble Drugs and Their Amorphous Formulation.
    Long CM; Tang K; Chokshi H; Fotaki N
    AAPS PharmSciTech; 2019 Feb; 20(3):113. PubMed ID: 30761437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
    Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
    Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When Interactions Between Bile Salts and Cyclodextrin Cause a Negative Food Effect: Dynamic Dissolution/Permeation Studies with Itraconazole (Sporanox®) and Biomimetic Media.
    Cuoco A; Eriksen JB; Luppi B; Brandl M; Bauer-Brandl A
    J Pharm Sci; 2023 May; 112(5):1372-1378. PubMed ID: 36539063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
    Hong JY; Kim JK; Song YK; Park JS; Kim CK
    J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
    Heikkinen AT; DeClerck L; Löbmann K; Grohganz H; Rades T; Laitinen R
    Pharmazie; 2015 Jul; 70(7):452-7. PubMed ID: 26373205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface area normalized dissolution to study differences in itraconazole-copovidone solid dispersions prepared by spray-drying and hot melt extrusion.
    Bhardwaj V; Trasi NS; Zemlyanov DY; Taylor LS
    Int J Pharm; 2018 Apr; 540(1-2):106-119. PubMed ID: 29425762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs.
    Galia E; Nicolaides E; Hörter D; Löbenberg R; Reppas C; Dressman JB
    Pharm Res; 1998 May; 15(5):698-705. PubMed ID: 9619777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.
    Kapsi SG; Ayres JW
    Int J Pharm; 2001 Oct; 229(1-2):193-203. PubMed ID: 11604272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.
    Jun SW; Kim MS; Jo GH; Lee S; Woo JS; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1529-37. PubMed ID: 16354397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidance of food effect on oral absorption profile of itraconazole by self-micellizing solid dispersion approach.
    Kojo Y; Kobayashi K; Matsunaga S; Suzuki H; Seto Y; Sato H; Onoue S
    Drug Metab Pharmacokinet; 2017 Oct; 32(5):273-276. PubMed ID: 28923421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
    Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
    AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.
    Stewart AM; Grass ME; Brodeur TJ; Goodwin AK; Morgen MM; Friesen DT; Vodak DT
    Mol Pharm; 2017 Jul; 14(7):2437-2449. PubMed ID: 28591516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3.
    Fuchs A; Leigh M; Kloefer B; Dressman JB
    Eur J Pharm Biopharm; 2015 Aug; 94():229-40. PubMed ID: 26032292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
    Jamil R; Polli JE
    Eur J Pharm Sci; 2022 Oct; 177():106274. PubMed ID: 35944878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
    Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
    Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution behavior of various drugs in different FaSSIF versions.
    Klumpp L; Leigh M; Dressman J
    Eur J Pharm Sci; 2020 Jan; 142():105138. PubMed ID: 31704344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.